ProfileGDS5822 / ILMN_2656282
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 86% 84% 82% 87% 85% 85% 83% 86% 85% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1291.686
GSM1276600PDAC Late Ablation Control 2233.784
GSM1276601PDAC Late Ablation Control 3240.182
GSM1276602PDAC Late Ablation 1340.187
GSM1276603PDAC Late Ablation 2266.485
GSM1276604PDAC Late Ablation 3275.685
GSM1303940PDAC Late Ablation_anti-CTLA4 119283
GSM1303941PDAC Late Ablation_anti-CTLA4 2374.786
GSM1303942PDAC Late Ablation_anti-CTLA4 3320.485